Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Malignant Melanoma

Free Subscription Articles published in J Immunol Retrieve available abstracts of 74 articles: HTML format Text format

Single Articles

December 2011
1. UZANA R , Eisenberg G, Sagi Y, Frankenburg S, et al
   Trogocytosis Is a Gateway to Characterize Functional Diversity in Melanoma-Specific CD8+ T Cell Clones.
   J Immunol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   November 2011
2. HAO J , Dong S, Xia S, He W, et al
   Regulatory role of Vgamma1 gammadelta T cells in tumor immunity through IL-4 production.
   J Immunol. 2011;187:4979-86.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. GARRIDO G , Rabasa A, Sanchez B, Lopez MV, et al
   Induction of immunogenic apoptosis by blockade of epidermal growth factor receptor activation with a specific antibody.
   J Immunol. 2011;187:4954-66.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   October 2011
4. QUI HZ , Hagymasi AT, Bandyopadhyay S, St Rose MC, et al
   CD134 plus CD137 dual costimulation induces Eomesodermin in CD4 T cells to program cytotoxic Th1 differentiation.
   J Immunol. 2011;187:3555-64.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   September 2011
5. BOUABE H , Liu Y, Moser M, Bosl MR, et al
   Novel highly sensitive IL-10-beta-lactamase reporter mouse reveals cells of the innate immune system as a substantial source of IL-10 in vivo.
   J Immunol. 2011;187:3165-76.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   August 2011
6. RODA JM , Sumner LA, Evans R, Phillips GS, et al
   Hypoxia-inducible factor-2alpha regulates GM-CSF-derived soluble vascular endothelial growth factor receptor 1 production from macrophages and inhibits tumor growth and angiogenesis.
   J Immunol. 2011;187:1970-6.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. QIAN J , Yi H, Guo C, Yu X, et al
   CD204 Suppresses Large Heat Shock Protein-Facilitated Priming of Tumor Antigen gp100-Specific T Cells and Chaperone Vaccine Activity against Mouse Melanoma.
   J Immunol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   July 2011
8. XIAO H , Peng Y, Hong Y, Liu Y, et al
   Lentivector Prime and Vaccinia Virus Vector Boost Generate High-Quality CD8 Memory T Cells and Prevent Autochthonous Mouse Melanoma.
   J Immunol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. WANG S , Villablanca EJ, De Calisto J, Gomes DC, et al
   MyD88-dependent TLR1/2 signals educate dendritic cells with gut-specific imprinting properties.
   J Immunol. 2011;187:141-50.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. IWATA-KAJIHARA T , Sumimoto H, Kawamura N, Ueda R, et al
    Enhanced cancer immunotherapy using STAT3-depleted dendritic cells with high Th1-inducing ability and resistance to cancer cell-derived inhibitory factors.
    J Immunol. 2011;187:27-36.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. TABBEKH M , Franciszkiewicz K, Haouas H, Lecluse Y, et al
    Rescue of tumor-infiltrating lymphocytes from activation-induced cell death enhances the antitumor CTL response in CD5-deficient mice.
    J Immunol. 2011;187:102-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. DUEWELL P , Kisser U, Heckelsmiller K, Hoves S, et al
    ISCOMATRIX adjuvant combines immune activation with antigen delivery to dendritic cells in vivo leading to effective cross-priming of CD8+ T cells.
    J Immunol. 2011;187:55-63.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2011
13. RAMACHANDRAN IR , Song W, Lapteva N, Seethammagari M, et al
    The phosphatase SRC homology region 2 domain-containing phosphatase-1 is an intrinsic central regulator of dendritic cell function.
    J Immunol. 2011;186:3934-45.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. KRYCZEK I , Wu K, Zhao E, Wei S, et al
    IL-17+ regulatory T cells in the microenvironments of chronic inflammation and cancer.
    J Immunol. 2011;186:4388-95.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
15. HEMON P , Jean-Louis F, Ramgolam K, Brignone C, et al
    MHC Class II Engagement by Its Ligand LAG-3 (CD223) Contributes to Melanoma Resistance to Apoptosis.
    J Immunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. LISIERO DN , Soto H, Liau LM, Prins RM, et al
    Enhanced Sensitivity to IL-2 Signaling Regulates the Clinical Responsiveness of IL-12-Primed CD8+ T Cells in a Melanoma Model.
    J Immunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. SODERQUEST K , Walzer T, Zafirova B, Klavinskis LS, et al
    Cutting edge: CD8+ T cell priming in the absence of NK cells leads to enhanced memory responses.
    J Immunol. 2011;186:3304-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. CARMI Y , Rinott G, Dotan S, Elkabets M, et al
    Microenvironment-derived IL-1 and IL-17 interact in the control of lung metastasis.
    J Immunol. 2011;186:3462-71.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
19. XU Y , Schnorrer P, Proietto A, Kowalski G, et al
    IL-10 controls cystatin C synthesis and blood concentration in response to inflammation through regulation of IFN regulatory factor 8 expression.
    J Immunol. 2011;186:3666-73.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. SETH S , Oberdorfer L, Hyde R, Hoff K, et al
    CCR7 essentially contributes to the homing of plasmacytoid dendritic cells to lymph nodes under steady-state as well as inflammatory conditions.
    J Immunol. 2011;186:3364-72.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. VERMA B , Jain R, Caseltine S, Rennels A, et al
    TCR mimic monoclonal antibodies induce apoptosis of tumor cells via immune effector-independent mechanisms.
    J Immunol. 2011;186:3265-76.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
22. DOMINGUEZ-SOTO A , Sierra-Filardi E, Puig-Kroger A, Perez-Maceda B, et al
    Dendritic cell-specific ICAM-3-grabbing nonintegrin expression on M2-polarized and tumor-associated macrophages is macrophage-CSF dependent and enhanced by tumor-derived IL-6 and IL-10.
    J Immunol. 2011;186:2192-200.
    PubMed     Text format     Related articles   
    
    
    
    
23. ZHANG Y , Luo F, Cai Y, Liu N, et al
    TLR1/TLR2 agonist induces tumor regression by reciprocal modulation of effector and regulatory T cells.
    J Immunol. 2011;186:1963-9.
    PubMed     Text format     Related articles   
    
    
    
    
24. BELLAVANCE EC , Kohlhapp FJ, Zloza A, O'Sullivan JA, et al
    Development of Tumor-Infiltrating CD8+ T Cell Memory Precursor Effector Cells and Antimelanoma Memory Responses Are the Result of Vaccination and TGF-{beta} Blockade during the Perioperative Period of Tumor Resection.
    J Immunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. PEI B , Speak AO, Shepherd D, Butters T, et al
    Diverse endogenous antigens for mouse NKT cells: self-antigens that are not glycosphingolipids.
    J Immunol. 2011;186:1348-60.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. DE BRITO C , Tomkowiak M, Ghittoni R, Caux C, et al
    CpG promotes cross-presentation of dead cell-associated antigens by pre-CD8alpha+ dendritic dells.
    J Immunol. 2011;186:1503-11.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. BJORCK P , Leong HX, Engleman EG
    Plasmacytoid dendritic cell dichotomy: identification of IFN-alpha producing cells as a phenotypically and functionally distinct subset.
    J Immunol. 2011;186:1477-85.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
28. CHEN T , Guo J, Yang M, Zhu X, et al
    Chemokine-Containing Exosomes Are Released from Heat-Stressed Tumor Cells via Lipid Raft-Dependent Pathway and Act as Efficient Tumor Vaccine.
    J Immunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. CHINNASAMY N , Wargo JA, Yu Z, Rao M, et al
    A TCR targeting the HLA-A*0201-restricted epitope of MAGE-A3 recognizes multiple epitopes of the MAGE-A antigen superfamily in several types of cancer.
    J Immunol. 2011;186:685-96.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. LIM JK , Obara CJ, Rivollier A, Pletnev AG, et al
    Chemokine receptor Ccr2 is critical for monocyte accumulation and survival in West Nile virus encephalitis.
    J Immunol. 2011;186:471-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
31. KUDELA P , Sun Z, Fourcade J, Janjic B, et al
    Epitope hierarchy of spontaneous CD4+ T cell responses to LAGE-1.
    J Immunol. 2011;186:312-22.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. COTE AL , Zhang P, O'Sullivan JA, Jacobs VL, et al
    Stimulation of the glucocorticoid-induced TNF receptor family-related receptor on CD8 T cells induces protective and high-avidity T cell responses to tumor-specific antigens.
    J Immunol. 2011;186:275-83.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2010
33. WILLIAMS P , Bouchentouf M, Rafei M, Romieu-Mourez R, et al
    A dendritic cell population generated by a fusion of GM-CSF and IL-21 induces tumor-antigen-specific immunity.
    J Immunol. 2010;185:7358-66.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. ZHANG P , Ozdemir T, Chung CY, Robertson GP, et al
    Sequential Binding of {alpha}v{beta}3 and ICAM-1 Determines Fibrin-Mediated Melanoma Capture and Stable Adhesion to CD11b/CD18 on Neutrophils.
    J Immunol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
35. EIKAWA S , Ohue Y, Kitaoka K, Aji T, et al
    Enrichment of Foxp3+ CD4 regulatory T cells in migrated T cells to IL-6- and IL-8-expressing tumors through predominant induction of CXCR1 by IL-6.
    J Immunol. 2010;185:6734-40.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. OLDFORD SA , Haidl ID, Howatt MA, Leiva CA, et al
    A critical role for mast cells and mast cell-derived IL-6 in TLR2-mediated inhibition of tumor growth.
    J Immunol. 2010;185:7067-76.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2010
37. TESTA JS , Apcher GS, Comber JD, Eisenlohr LC, et al
    Exosome-Driven Antigen Transfer for MHC Class II Presentation Facilitated by the Receptor Binding Activity of Influenza Hemagglutinin.
    J Immunol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2010
38. REBOULET RA , Hennies CM, Garcia Z, Nierkens S, et al
    Prolonged antigen storage endows merocytic dendritic cells with enhanced capacity to prime anti-tumor responses in tumor-bearing mice.
    J Immunol. 2010;185:3337-47.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. ZHU Y , Ju S, Chen E, Dai S, et al
    T-bet and eomesodermin are required for T cell-mediated antitumor immune responses.
    J Immunol. 2010;185:3174-83.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. LIN PY , Sun L, Thibodeaux SR, Ludwig SM, et al
    B7-H1-dependent sex-related differences in tumor immunity and immunotherapy responses.
    J Immunol. 2010;185:2747-53.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
41. ZOU T , Caton AJ, Koretzky GA, Kambayashi T, et al
    Dendritic cells induce regulatory T cell proliferation through antigen-dependent and -independent interactions.
    J Immunol. 2010;185:2790-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. WINGENDER G , Krebs P, Beutler B, Kronenberg M, et al
    Antigen-specific cytotoxicity by invariant NKT cells in vivo is CD95/CD178-dependent and is correlated with antigenic potency.
    J Immunol. 2010;185:2721-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2010
43. LY LV , Baghat A, Versluis M, Jordanova ES, et al
    In Aged Mice, Outgrowth of Intraocular Melanoma Depends on Proangiogenic M2-Type Macrophages.
    J Immunol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
44. ULLAND TK , Buchan BW, Ketterer MR, Fernandes-Alnemri T, et al
    Cutting Edge: Mutation of Francisella tularensis mviN Leads to Increased Macrophage Absent in Melanoma 2 Inflammasome Activation and a Loss of Virulence.
    J Immunol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
45. MASTROFRANCESCO A , Kokot A, Eberle A, Gibbons NC, et al
    KdPT, a tripeptide derivative of alpha-melanocyte-stimulating hormone, suppresses IL-1 beta-mediated cytokine expression and signaling in human sebocytes.
    J Immunol. 2010;185:1903-11.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2010
46. RAUSCH MP , Irvine KR, Antony PA, Restifo NP, et al
    GILT Accelerates Autoimmunity to the Melanoma Antigen Tyrosinase-Related Protein 1.
    J Immunol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
47. FAHAM A , Altin JG
    Antigen-Containing Liposomes Engrafted with Flagellin-Related Peptides Are Effective Vaccines That Can Induce Potent Antitumor Immunity and Immunotherapeutic Effect.
    J Immunol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
48. HE W , Hao J, Dong S, Gao Y, et al
    Naturally activated V gamma 4 gamma delta T cells play a protective role in tumor immunity through expression of eomesodermin.
    J Immunol. 2010;185:126-33.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
49. KERZERHO J , Adotevi O, Castelli FA, Dosset M, et al
    The angiogenic growth factor and biomarker midkine is a tumor-shared antigen.
    J Immunol. 2010;185:418-23.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2010
50. TSUCHIYA K , Hara H, Kawamura I, Nomura T, et al
    Involvement of Absent in Melanoma 2 in Inflammasome Activation in Macrophages Infected with Listeria monocytogenes.
    J Immunol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
51. AHMAD U , Ali R, Lebastchi AH, Qin L, et al
    IFN-{gamma} Primes Intact Human Coronary Arteries and Cultured Coronary Smooth Muscle Cells to Double-Stranded RNA- and Self-RNA-Induced Inflammatory Responses by Upregulating TLR3 and Melanoma Differentiation-Associated Gene 5.
    J Immunol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
52. FOURCADE J , Sun Z, Kudela P, Janjic B, et al
    Human tumor antigen-specific helper and regulatory T cells share common epitope specificity but exhibit distinct T cell repertoire.
    J Immunol. 2010;184:6709-18.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
53. ABDUL-ALIM CS , Li Y, Yee C
    Conditional superagonist CTL ligands for the promotion of tumor-specific CTL responses.
    J Immunol. 2010;184:6514-21.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
54. FRANKEL TL , Burns WR, Peng PD, Yu Z, et al
    Both CD4 and CD8 T cells mediate equally effective in vivo tumor treatment when engineered with a highly avid TCR targeting tyrosinase.
    J Immunol. 2010;184:5988-98.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
55. BIALER G , Horovitz-Fried M, Ya'acobi S, Morgan RA, et al
    Selected murine residues endow human TCR with enhanced tumor recognition.
    J Immunol. 2010;184:6232-41.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2010
56. JOHNSON LD , Jameson SC
    Self-specific CD8+ T cells maintain a semi-naive state following lymphopenia-induced proliferation.
    J Immunol. 2010;184:5604-11.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2010
57. BRIDLE BW , Li J, Jiang S, Chang R, et al
    Immunotherapy can reject intracranial tumor cells without damaging the brain despite sharing the target antigen.
    J Immunol. 2010;184:4269-75.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2010
58. GARCIA-HERNANDEZ MD , Hamada H, Reome JB, Misra SK, et al
    Adoptive Transfer of Tumor-Specific Tc17 Effector T Cells Controls the Growth of B16 Melanoma in Mice.
    J Immunol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
59. MARTTILA-ICHIHARA F , Castermans K, Auvinen K, Oude Egbrink MG, et al
    Small-molecule inhibitors of vascular adhesion protein-1 reduce the accumulation of myeloid cells into tumors and attenuate tumor growth in mice.
    J Immunol. 2010;184:3164-73.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
60. DILILLO DJ , Yanaba K, Tedder TF
    B Cells Are Required for Optimal CD4+ and CD8+ T Cell Tumor Immunity: Therapeutic B Cell Depletion Enhances B16 Melanoma Growth in Mice.
    J Immunol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
61. PILON-THOMAS S , Mackay A, Vohra N, Mule JJ, et al
    Blockade of Programmed Death Ligand 1 Enhances the Therapeutic Efficacy of Combination Immunotherapy against Melanoma.
    J Immunol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
62. GLASNER A , Avraham R, Rosenne E, Benish M, et al
    Improving survival rates in two models of spontaneous postoperative metastasis in mice by combined administration of a beta-adrenergic antagonist and a cyclooxygenase-2 inhibitor.
    J Immunol. 2010;184:2449-57.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2010
63. WANG Y , Cella M, Gilfillan S, Colonna M, et al
    Cutting Edge: Polyinosinic:Polycytidylic Acid Boosts the Generation of Memory CD8 T Cells through Melanoma Differentiation-Associated Protein 5 Expressed in Stromal Cells.
    J Immunol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
64. FRASZCZAK J , Trad M, Janikashvili N, Cathelin D, et al
    Peroxynitrite-dependent killing of cancer cells and presentation of released tumor antigens by activated dendritic cells.
    J Immunol. 2010;184:1876-84.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
65. SALEM ML , Al-Khami AA, El-Naggar SA, Diaz-Montero CM, et al
    Cyclophosphamide induces dynamic alterations in the host microenvironments resulting in a Flt3 ligand-dependent expansion of dendritic cells.
    J Immunol. 2010;184:1737-47.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
66. SORENSEN EW , Gerber SA, Frelinger JG, Lord EM, et al
    IL-12 suppresses vascular endothelial growth factor receptor 3 expression on tumor vessels by two distinct IFN-gamma-dependent mechanisms.
    J Immunol. 2010;184:1858-66.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
67. DIETL K , Renner K, Dettmer K, Timischl B, et al
    Lactic acid and acidification inhibit TNF secretion and glycolysis of human monocytes.
    J Immunol. 2010;184:1200-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
68. DIAO J , Zhao J, Winter E, Cattral MS, et al
    Recruitment and differentiation of conventional dendritic cell precursors in tumors.
    J Immunol. 2010;184:1261-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
69. LUNDQVIST A , Su S, Rao S, Childs R, et al
    Cutting edge: bortezomib-treated tumors sensitized to NK cell apoptosis paradoxically acquire resistance to antigen-specific T cells.
    J Immunol. 2010;184:1139-42.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
70. SU X , Ye J, Hsueh EC, Zhang Y, et al
    Tumor microenvironments direct the recruitment and expansion of human Th17 cells.
    J Immunol. 2010;184:1630-41.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2010
71. WATCHMAKER PB , Berk E, Muthuswamy R, Mailliard RB, et al
    Independent regulation of chemokine responsiveness and cytolytic function versus CD8+ T cell expansion by dendritic cells.
    J Immunol. 2010;184:591-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
72. CUFF S , Dolton G, Matthews RJ, Gallimore A, et al
    Antigen specificity determines the pro- or antitumoral nature of CD8+ T cells.
    J Immunol. 2010;184:607-14.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
73. BUCHAU AS , Morizane S, Trowbridge J, Schauber J, et al
    The host defense peptide cathelicidin is required for NK cell-mediated suppression of tumor growth.
    J Immunol. 2010;184:369-78.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2009
74. HAN L , Wang W, Fang Y, Feng Z, et al
    Soluble B and T Lymphocyte Attenuator Possesses Antitumor Effects and Facilitates Heat Shock Protein 70 Vaccine-Triggered Antitumor Immunity against a Murine TC-1 Cervical Cancer Model In Vivo.
    J Immunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: